Benzo[a]pyrene structure, CAS 50-32-8

Benzo[a]pyrene

CAS Number50-32-8

SynonymsUNII-3417WMA06D; Benzo[a]pyrene (Ames grade); Benzo[A]Pyrene; Benzo(d,e,f)chrysene; Benzo(a)pyrene; Benzo[a]pyren; benzo[1,2,5]thiadiazole-4-sulfonyl chloride; 2,1,3-benzothiadiazol-4-sulfonyl chloride; 3,4-Benzpyrene; 3,4-Benz(a)pyrene; 4,5-BENZPYRENE; 2,1,3-Benzothiadiazole,4-chlorosulfonyl; 3,4-benzopyrene; 2,1,3-benzothiadiazole-4-sulphonyl chloride; 1,2-Benzpyrene (VAN); Benzo[pqr]tetraphene; Benzopyrene; 4-Chlorosulfonyl-2,1,3-benzothiadiazole; 2,1,3-benzothiadiazole-4-sulfonylchloride; 3,4-Benzo(a)pyrene; Benzo-2,1,3-thiadiazole-4-sulphonyl chloride; Benzo[c][1,2,5]thiadiazole-4-sulfonyl chloride; EINECS 200-028-5; benz[a]pyrene; benzo[2,1,3]thiadiazole-4-sulfonyl chloride; 6,7-Benzopyrene; MFCD00003602; 1,2-Benzpyrene

Molecular FormulaC20H12

Molecular Weight252.31

Purity≥96 (HPLC)%

Density1.3±0.1 g/cm3

Boiling Point495 °C (lit.)

Melting Point177-180 °C (lit.)

Flash Point

Appearancesolid

EINECS200-028-5

MSDSChineseEnglish

Symbol6.1

Signal WordWarning

Cat. No.: 2A-9016548 Purity: ≥96 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 50-32-8 ] Purity: ≥96 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number50-32-8
Catalog No.2A-9016548
Chinese Name苯并[a]芘
SynonymsUNII-3417WMA06D; Benzo[a]pyrene (Ames grade); Benzo[A]Pyrene; Benzo(d,e,f)chrysene; Benzo(a)pyrene; Benzo[a]pyren; benzo[1,2,5]thiadiazole-4-sulfonyl chloride; 2,1,3-benzothiadiazol-4-sulfonyl chloride; 3,4-Benzpyrene; 3,4-Benz(a)pyrene; 4,5-BENZPYRENE; 2,1,3-Benzothiadiazole,4-chlorosulfonyl; 3,4-benzopyrene; 2,1,3-benzothiadiazole-4-sulphonyl chloride; 1,2-Benzpyrene (VAN); Benzo[pqr]tetraphene; Benzopyrene; 4-Chlorosulfonyl-2,1,3-benzothiadiazole; 2,1,3-benzothiadiazole-4-sulfonylchloride; 3,4-Benzo(a)pyrene; Benzo-2,1,3-thiadiazole-4-sulphonyl chloride; Benzo[c][1,2,5]thiadiazole-4-sulfonyl chloride; EINECS 200-028-5; benz[a]pyrene; benzo[2,1,3]thiadiazole-4-sulfonyl chloride; 6,7-Benzopyrene; MFCD00003602; 1,2-Benzpyrene
Molecular FormulaC20H12
Molecular Weight252.31
Purity≥96 (HPLC)
Density1.3±0.1 g/cm3
Boiling Point495 °C (lit.)
Melting Point177-180 °C (lit.)
Appearancesolid
Water SolubilityWater solubility: insoluble; soluble in: benzene,
Storage ConditionStore in a cool, ventilated warehouse. Keep away f
PackagingIII
ApplicationBenzo[a]pyrene shows lung carcinogenicity in animal models, and they are frequently used in chemoprevention studies.
EINECS200-028-5
HTC2902909090
UN(IATA)UN 1145
PubChem ID24891610
MDL NumberMFCD00003602
SMILESc1ccc2c(c1)cc3ccc4cccc5ccc2c3c45
InChI1S/C20H12/c1-2-7-17-15(4-1)12-16-9-8-13-5-3-6-14-10-11-18(17)20(16)19(13)14/h1-12H
InChI KeyFMMWHPNWAFZXNH-UHFFFAOYSA-N
Beilstein/REAXYS1911333
NACRES CodeNA.25
UNSPSC12352005
Hazard Symbols6.1
Risk CodesR45;R11;R38;R50/53;R65;R67
Safety DescriptionS53;S45;S61;S62
MSDSmsds/16548_1_50_32_8.pdf
BioactivityBenzo[a]pyrene shows lung carcinogenicity in animal models, and it is frequently used in chemoprevention studies. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Cancer In Vivo Statistically significant decrease is observed at 7 weeks in females receiving 1.0 mg Benzo[a]pyrene (B[a]P) compare with the vehicle group. As lung tumorigenesis induced by Benzo[a]pyrene is dose dependent in female A/J mice. The incidence of hyperplasia values in females treating with 0.25, 0.50, and 1.0 mg Benzo[a]pyrene are significantly higher than in the vehicle-treated group. The incidence of adenoma in females receiving 1.0 mg Benzo[a]pyrene is significantly higher than in the vehicle group. The multiplicity of hyperplasia in females receiving 0.50 or 1.0 mg Benzo[a]pyrene is significantly higher than in the vehicle group. The multiplicity of adenoma in the group treated with 1.0 mg is also significantly higher than in the vehicle group. The incidences of hyperplasia and adenoma in female A/J mice are significantly increased by Benzo[a]pyrene in a dose-dependent manner[1]. Benzo[a]pyrene induces an average of 9.38±1.75 tumors with an average tumor load of 19.53±3.81 mm3 (P<0.05 compare to control). Benzo[a]pyrene administration significantly (P<0.05) decreases cAMP levels in tumors with adjacent lung tissues. The expression level of PDE4D gene is also increased by Benzo[a]pyrene administration[2]. Animal Admin Female A/J mice are randomized into eight groups (n=8): (i) control; (ii)Benzo[a]pyrene (B(a)P)+vehicle (methocel); (iii) Benzo[a]pyrene+roflumilast 1 mg/kg; (iv) Benzo[a]pyrene+roflumilast 5 mg/kg; (v) Benzo[a]pyrene+aerozolie phosphate-buffer saline (PBS); (vi) Benzo[a]pyrene+aerosolize budesonide 2.25 mg/mL; (vii) Benzo[a]pyrene+aerosolized budesonide 2.25 mg/mL+roflumilast 1 mg/kg; and (viii) Benzo[a]pyrene+aerosolize budesonide 2.25 mg/mL+roflumilast 5 mg/kg groups. A single dose of Benzo[a]pyrene in corn oil is given intraperitoneally once at 100 mg/kg body weight. Roflumilast (1 or 5 mg/kg) is started 2 weeks after Benzo[a]pyrene. It is continued for 26 weeks (3 days/week) via oral gavage. Mice in the Benzo[a]pyrene+vehicle group are treated with an equal volume of methocel as solvent control. Aerosolizing budesonide is administrated by inhaling route as an aerosol at a dose of 2.25 mg/mL for 2 min per application at 2 weeks after Benzo[a]pyrene. It is continued for 26 weeks (5 days/week). PBS is also used as solvent control by inhaling route after Benzo[a]pyrene administration in the Benzo[a]pyrene+PBS group. Mice are killed at 28 weeks after exposure to Benzo[a]pyrene. Their lungs are excised and stored at -70 °C[2]. References [1]. Saeko Onami, et al. Dosimetry for lung tumorigenesis induced by urethane, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and benzo[a]pyrene (B[a]P) in A/JJmsSlc mice. J Toxicol Pathol. 2017 Jul; 30(3): 209-216. [2]. Yeo CD, et al. Roflumilast treatment inhibits lung carcinogenesis in benzo(a)pyrene-induced murine lung cancer model. Eur J Pharmacol. 2017 Oct 5;812:189- Chemical & Physical Properties Density 1.3±0.1 g/cm3 Boiling Point 495.0±0.0 °C at 760 mmHg Melting Point 177-180°C Molecular Formula C20H12 Molecular Weight 252.309 Flash Point 228.6±13.7 °C Exact Mass 252.093903 LogP 6.40 Vapour Pressure 0.0±0.6 mmHg at 25°C Index of Refraction 1.887 InChIKey FMMWHPNWAFZXNH-UHFFFAOYSA-N SMILES c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34 Stability Stable. Incompatible with strong oxidizing agents.
Use ofBenzo[a]pyrene shows lung carcinogenicity in animal models, and it is frequently used in chemoprevention studies. Properties Articles167 Name benzo[a]pyrene Synonym More Synonyms Benzo(a)pyrene Biological Activity Description Benzo[a]pyrene shows lung carcinogenicity in animal models, and it is frequently used in chemoprevention studies. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Cancer References [1]. Saeko Onami, et al. Dosimetry for lung tumorigenesis induced by urethane, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and benzo[a]pyrene (B[a]P) in A/JJmsSlc mice. J Toxicol Pathol. 2017 Jul; 30(3): 209-216. [2]. Yeo CD, et al. Roflumilast treatment inhibits lung carcinogenesis in benzo(a)pyrene-induced murine lung cancer model. Eur J Pharmacol. 2017 Oct 5;812:189- Chemical & Physical Properties Molecular Formula C20H12 Exact Mass 252.093903 Index of Refraction 1.887 InChIKey FMMWHPNWAFZXNH-UHFFFAOYSA-N Stability Stable. Incompatible with strong oxidizing agents.
Tax Rebate9.0%
SupervisionNone. MFN tariff: 2.0%. Ordinary tariff: 30.0%
Transport InfoProduct name: Chemical name
Related Products in Specialty Chemicals
Zirconium(Ⅳ) oxide chloride-8-hydrate13520-92-82A-9016216
Zirconium(IV) hydrogenphosphate13772-29-72A-9016217
2-Chloropropionic acid598-78-72A-9016218
β-Methylnaphthalene91-57-62A-9016219
Bistratene A115566-02-42A-9016534
Adiphenine hydrochloride50-42-02A-9016553
Desipramine50-47-52A-9016557
Oxytocin50-56-62A-0200171
Lypressin50-57-72A-9016565
5-Hydroxytryptamine50-67-92A-9016570
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA